Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?

Author(s): Georgios Giannopoulos, Christos Angelidis, Nikolaos Papoutsidakis, Vasiliki Panagopoulou, Michael W. Cleman, John Lekakis, Spyridon Deftereos

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 36 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Colchicine has recently gained considerable attention in the field of cardiovascular research, after a number of studies showed that it may be of use in several settings of cardiovascular disease, including chronic coronary artery disease and following stent implantation. Its unique anti-inflammatory mechanism of action makes it safe to use in patients with cardiovascular disease, unlike most – if not all – currently available antiinflammatory agents. While its prophylactic and therapeutic value is well-established in certain conditions involving an acute inflammatory response, e.g. pericarditis, in other conditions, including coronary artery disease and heart failure, which are associated with a chronic low-grade inflammatory state, the evidence regarding its potential use remains sparse. In this concise review, we present key features of this drug and the rationale for colchicine therapy, in the context of acute and chronic coronary artery disease, as well as in ischemic heart failure and critically examine the evidence concerning a possible future role of colchicine treatment in these conditions.

Keywords: Inflammation, treatment, ischemic, drug, pharmacotherapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [4177 - 4188]
Pages: 12
DOI: 10.2174/0929867322666151015120458
Price: $65

Article Metrics

PDF: 34